Nutex Health Inc.
NUTX Healthcare Medical Care Facilities
Nutex Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $875.3 million, up 82.4% from fiscal 2024. In the quarter to June 2026, revenue fell 13.6%, EPS grew 424.8%, free cash flow grew 19.4% and total debt fell 1.69%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
Follow NUTX
Nutex Health Inc. (NUTX) EV/Sales
As of 16 October 2026, Nutex Health Inc. (NUTX) trades at a EV/Sales of 1.6×. Over the past ten years it has ranged from 0.8× (March 2026) to 58.0× (April 2022); the current reading is higher than 56% of that period. That is above the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.3× | 52.32% |
| FY2024 | 0.9× | (40.90%) |
| FY2023 | 1.5× | (78.05%) |
| FY2022 | 6.7× | (88.44%) |
| FY2021 | 58.0× | 0.00% |
| FY2020 | 58.0× | 0.00% |
| FY2019 | 58.0× | 0.00% |
| FY2018 | 58.0× | 0.00% |
| FY2017 | 58.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.5× | 72.46% |
| Mar 2026 | 0.9× | (34.53%) |
| Dec 2025 | 1.3× | 53.86% |
| Sep 2025 | 0.9× | (28.52%) |
| 39 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| CMPS COMPASS Pathways PLC Sponsored ADR compare | n/m |
| AGL Agilon Health, Inc. compare | 0.2× |
| ARDT Ardent Health, Inc. compare | 0.3× |
| AMN AMN Healthcare Services Inc compare | 0.6× |
| HCSG Healthcare Services Group, Inc. compare | 0.7× |
| INNV InnovAge Holding Corp. compare | 1.1× |
| PNTG The Pennant Group, Inc. compare | 1.5× |
| NUTX Nutex Health Inc. | 1.6× |
| USPH U.S. Physical Therapy, Inc. compare | 1.8× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)